147
Views
11
CrossRef citations to date
0
Altmetric
Brief Report

Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination

, , &
Pages 2711-2721 | Accepted 25 Aug 2009, Published online: 24 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gianni Allais & Chiara Benedetto. (2016) Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine. Drug Design, Development and Therapy 10, pages 3225-3236.
Read now
Leslie Kelman, Samira Q. Harper, Xiaojun Hu & John C. Campbell. (2010) Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline. Current Medical Research and Opinion 26:9, pages 2097-2104.
Read now

Articles from other publishers (9)

Marcel Gebhardt, Peter Kropp, Frank Hoffmann & Uwe K. Zettl. (2022) Headache in Multiple Sclerosis - Pharmacological Aspects. Current Pharmaceutical Design 28:6, pages 445-453.
Crossref
Stewart J Tepper, Tamar Lin, Tal Montal, Alon Ironi & Carrie Dougherty. (2020) Real-world Experience with Remote Electrical Neuromodulation in the Acute Treatment of Migraine. Pain Medicine 21:12, pages 3522-3529.
Crossref
Gianni Allais & Chiara Benedetto. (2012) A review of the use of frovatriptan in the treatment of menstrually related migraine. Therapeutic Advances in Neurological Disorders 6:2, pages 55-67.
Crossref
Veronica Villani, Laura De Giglio, Giuliano Sette, Carlo Pozzilli, Marco Salvetti & Luca Prosperini. (2012) Determinants of the severity of comorbid migraine in multiple sclerosis. Neurological Sciences 33:6, pages 1345-1353.
Crossref
Gianni Allais, Vincenzo Tullo, Stefano Omboni, Chiara Benedetto, Grazia Sances, Dario Zava, Michel D. Ferrari & Gennaro Bussone. (2012) Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies. Neurological Sciences 33:S1, pages 65-69.
Crossref
Marco Bartolini, Maria Adele Giamberardino, Carlo Lisotto, Paolo Martelletti, Davide Moscato, Biagio Panascia, Lidia Savi, Luigi Alberto Pini, Grazia Sances, Patrizia Santoro, Giorgio Zanchin, Stefano Omboni, Michel D. Ferrari, Filippo Brighina & Brigida Fierro. (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. The Journal of Headache and Pain 12:3, pages 361-368.
Crossref
Pietro Cortelli, Gianni Allais, Vincenzo Tullo, Chiara Benedetto, Dario Zava, Stefano Omboni & Gennaro Bussone. (2011) Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies. Neurological Sciences 32:S1, pages 95-98.
Crossref
Lidia Savi, Stefano Omboni, Carlo Lisotto, Giorgio Zanchin, Michel D. Ferrari, Dario Zava & Lorenzo Pinessi. (2010) A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. The Journal of Headache and Pain 12:2, pages 219-226.
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.